Monday, 31 August 2026European Markets

OCEANTEAM Stock Impressive Rise On Wednesday, Outperforms Market

Loading stream...

(VIANEWS) - The Market ended the session with OCEANTEAM (OTS.OL) rising 25% to kr1.30 on Wednesday, following the last session's upward trend. Oslo Børs Benchmark Index_GI jumped 0.24% to kr1,371.21, after five sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

OCEANTEAM's last close was kr1.30, 35.32% below its 52-week high of kr2.01.

About OCEANTEAM

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.25.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -21.79%.

More news about OCEANTEAM (OTS.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com